Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
6.30% $3.88
America/New_York / 26 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 127.47 mill |
EPS: | -2.07 |
P/E: | -1.870 |
Earnings Date: | May 16, 2024 |
SharesOutstanding: | 32.85 mill |
Avg Daily Volume: | 0.0030 mill |
RATING 2024-04-26 |
---|
B- |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Strong Sell | |
Return On Asset: | Sell | |
DE: | Neutral | |
P/E: | Sell | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -1.870 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.32x |
Company: PE -1.870 | industry: PE 5.88 |
DISCOUNTED CASH FLOW VALUE |
---|
$4.96 (27.77%) $1.078 |
Date: 2024-04-26 |
Expected Trading Range (DAY) |
---|
$ 3.66 - 4.10 ( +/- 5.72%) |
ATR Model: 14 days |